Primient, a global leader in biosolutions and plant-based ingredients, purchased the remaining ownership interest in Primient Covation, LLC (“Primient Covation”). The acquisition establishes Primient as the sole owner of the company, effective February 27, 2026.
“Today marks an important milestone for Primient as we complete the acquisition of Primient Covation and bring the business wholly into our organization,” said Jim Stutelberg, Primient CEO. “Full ownership of Primient Covation strengthens our leadership position in biomanufacturing and reflects our long‑term commitment to investing for growth in bio‑industrial solutions. We are thrilled to welcome our new colleagues fully into the Primient family and we are already working together to make this business even better.”
Read the initial press release regarding this announcement here.
For more details, contact corporatecommunications@primient.com.